Exxonmobil Investment Management Has Lowered T Rowe Price Group (TROW) Position By $557,960; Core Laboratories N.V. (CLB) SI Decreased By 7.64%

April 24, 2018 - By David Stenberg

T. Rowe Price Group, Inc. (NASDAQ:TROW) Logo

Core Laboratories N.V. (NYSE:CLB) had a decrease of 7.64% in short interest. CLB’s SI was 6.51M shares in April as released by FINRA. Its down 7.64% from 7.05M shares previously. With 341,100 avg volume, 19 days are for Core Laboratories N.V. (NYSE:CLB)’s short sellers to cover CLB’s short positions. The SI to Core Laboratories N.V.’s float is 14.98%. The stock increased 1.02% or $1.24 during the last trading session, reaching $122.74. About 583,856 shares traded or 25.67% up from the average. Core Laboratories N.V. (NYSE:CLB) has declined 4.05% since April 24, 2017 and is downtrending. It has underperformed by 15.60% the S&P500.

Exxonmobil Investment Management Inc decreased T Rowe Price Group Inc (TROW) stake by 12.22% reported in 2017Q4 SEC filing. Exxonmobil Investment Management Inc sold 5,365 shares as T Rowe Price Group Inc (TROW)’s stock rose 0.82%. The Exxonmobil Investment Management Inc holds 38,528 shares with $4.04 million value, down from 43,893 last quarter. T Rowe Price Group Inc now has $26.57 billion valuation. The stock increased 0.17% or $0.18 during the last trading session, reaching $108.62. About 702,567 shares traded. T. Rowe Price Group, Inc. (NASDAQ:TROW) has risen 56.88% since April 24, 2017 and is uptrending. It has outperformed by 45.33% the S&P500.

Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the gas and oil industry in the United States, Canada, and internationally. The company has market cap of $5.42 billion. It operates through three divisions: Reservoir Description, Production Enhancement, and Reservoir Management. It has a 65.29 P/E ratio. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples.

Among 23 analysts covering Core Laboratories (NYSE:CLB), 12 have Buy rating, 0 Sell and 11 Hold. Therefore 52% are positive. Core Laboratories had 54 analyst reports since August 24, 2015 according to SRatingsIntel. The rating was maintained by Howard Weil on Friday, January 29 with “Sector Perform”. The rating was maintained by Cowen & Co with “Hold” on Friday, July 7. The firm has “Market Perform” rating by Cowen & Co given on Monday, October 26. The stock of Core Laboratories N.V. (NYSE:CLB) earned “Buy” rating by Loop Capital on Friday, April 21. The firm earned “Neutral” rating on Friday, March 18 by Citigroup. RBC Capital Markets maintained the shares of CLB in report on Friday, October 23 with “Outperform” rating. The firm has “Hold” rating by Piper Jaffray given on Monday, October 23. Citigroup maintained the shares of CLB in report on Monday, May 16 with “Neutral” rating. The firm has “Neutral” rating given on Thursday, September 1 by Credit Suisse. UBS maintained the shares of CLB in report on Wednesday, July 26 with “Neutral” rating.

Investors sentiment decreased to 0.86 in 2017 Q4. Its down 0.21, from 1.07 in 2017Q3. It turned negative, as 52 investors sold Core Laboratories N.V. shares while 109 reduced holdings. 54 funds opened positions while 85 raised stakes. 49.56 million shares or 0.63% more from 49.25 million shares in 2017Q3 were reported. Ngam Advsr Ltd Partnership holds 0.19% of its portfolio in Core Laboratories N.V. (NYSE:CLB) for 172,727 shares. Farmers Merchants Investments reported 20,139 shares. Pacific Global Inv Mgmt accumulated 2,292 shares. Forward Management Limited Liability Corp stated it has 2,891 shares or 0.04% of all its holdings. The California-based Snyder Cap Mgmt L P has invested 0.19% in Core Laboratories N.V. (NYSE:CLB). Janney Montgomery Scott Limited Liability invested 0.02% in Core Laboratories N.V. (NYSE:CLB). Fdx Advsrs holds 16,263 shares or 0.05% of its portfolio. Rhumbline Advisers invested in 41,976 shares or 0.01% of the stock. Arrowmark Colorado Ltd Liability owns 52,000 shares for 0.06% of their portfolio. 12,886 were accumulated by Forte Capital Adv. Peoples Financial Corporation, a Pennsylvania-based fund reported 42 shares. California Pub Employees Retirement Sys, California-based fund reported 94,646 shares. Schwab Charles Invest Mngmt stated it has 164,348 shares or 0.01% of all its holdings. Dimensional Fund Advisors L P has invested 0.01% in Core Laboratories N.V. (NYSE:CLB). Invesco Limited reported 508,224 shares.

Among 15 analysts covering T. Rowe Price Group Inc (NASDAQ:TROW), 5 have Buy rating, 2 Sell and 8 Hold. Therefore 33% are positive. T. Rowe Price Group Inc has $128.0 highest and $65 lowest target. $98.27’s average target is -9.53% below currents $108.62 stock price. T. Rowe Price Group Inc had 81 analyst reports since August 5, 2015 according to SRatingsIntel. Barclays Capital maintained T. Rowe Price Group, Inc. (NASDAQ:TROW) rating on Tuesday, August 9. Barclays Capital has “Equal-Weight” rating and $76 target. As per Friday, March 17, the company rating was downgraded by Morgan Stanley. Argus Research maintained the stock with “Buy” rating in Wednesday, December 7 report. The firm earned “Hold” rating on Thursday, April 5 by Credit Suisse. The stock has “Hold” rating by Keefe Bruyette & Woods on Tuesday, January 30. The stock of T. Rowe Price Group, Inc. (NASDAQ:TROW) has “Hold” rating given on Friday, September 9 by Deutsche Bank. The firm earned “Underweight” rating on Friday, October 27 by Barclays Capital. The stock has “Neutral” rating by Credit Suisse on Thursday, February 22. Keefe Bruyette & Woods maintained the shares of TROW in report on Tuesday, April 10 with “Hold” rating. Jefferies maintained T. Rowe Price Group, Inc. (NASDAQ:TROW) rating on Wednesday, January 10. Jefferies has “Buy” rating and $128.0 target.

Analysts await T. Rowe Price Group, Inc. (NASDAQ:TROW) to report earnings on April, 25 before the open. They expect $1.63 earnings per share, up 38.14% or $0.45 from last year’s $1.18 per share. TROW’s profit will be $398.69 million for 16.66 P/E if the $1.63 EPS becomes a reality. After $1.52 actual earnings per share reported by T. Rowe Price Group, Inc. for the previous quarter, Wall Street now forecasts 7.24% EPS growth.

T. Rowe Price Group, Inc. (NASDAQ:TROW) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 David Stenberg

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: